1. A randomized clinical trial evaluating the efficacy and safety of the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy. (3rd October 2017) Authors: Shankar, R. Ravi; Inzucchi, Silvio E.; Scarabello, Victoria; Gantz, Ira; Kaufman, Keith D.; Lai, Eseng; Ceesay, Paulette; Suryawanshi, Shailaja; Engel, Samuel S. Journal: Current medical research and opinion Issue: Volume 33:Number 10(2017) Page Start: 1853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes. Issue 2 (22nd December 2021) Authors: Shankar, R. Ravi; Zeitler, Philip; Deeb, Asma; Jalaludin, Muhammad Yazid; Garcia, Raymundo; Newfield, Ron S.; Samoilova, Yulia; Rosario, Carmen A.; Shehadeh, Naim; Saha, Chandan K.; Zhang, Yilong; Zilli, Martina; Scherer, Lynn W.; Lam, Raymond L. H.; Golm, Gregory T.; Engel, Samuel S.; Kaufman, K... Journal: Pediatric diabetes Issue: Volume 23:Issue 2(2022) Page Start: 173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A randomized clinical trial of the safety and efficacy of sitagliptin in patients with type 2 diabetes mellitus inadequately controlled by acarbose alone. (3rd April 2017) Authors: Wang, Weiqing; Ning, Guang; Ma, Jianhua; Liu, Xiaomin; Zheng, Shaoxiong; Wu, Fan; Xu, Lei; O'Neill, Edward A.; Fujita, Kenji P.; Engel, Samuel S.; Kaufman, Keith D.; Shankar, R. Ravi Journal: Current medical research and opinion Issue: Volume 33:Number 4(2017) Page Start: 693 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes. (April 2018) Authors: Home, Philip; Shankar, R. Ravi; Gantz, Ira; Iredale, Carol; O'Neill, Edward A.; Jain, Lokesh; Pong, Annpey; Suryawanshi, Shailaja; Engel, Samuel S.; Kaufman, Keith D.; Lai, Eseng Journal: Diabetes research and clinical practice Issue: Volume 138(2018) Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Association between hypoglycemia risk and hemoglobin A1C in patients with type 2 diabetes mellitus. (2nd August 2016) Authors: Yu, Shengsheng; Fu, Alex Z.; Engel, Samuel S.; Shankar, R. Ravi; Radican, Larry Journal: Current medical research and opinion Issue: Volume 32:Number 8(2016:Aug.) Page Start: 1409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comparison of diabetes conversion rates among Chinese prediabetic population using different diagnosis criteria. (October 2016) Authors: Zhao, Zhenping; Man, Tengfei; Zhang, Mei; Wang, Tongtong; Huang, Zhengjing; Liu, Shusen; Li, Yichong; Li, Chun; Engel, Samuel S.; Shankar, R. Ravi; Tu, Yingmei; Wang, Linhong; Brodovicz, Kimberly; Wang, Limin Journal: Diabetes research and clinical practice Issue: Volume 120(2016)Supplement 1 Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Direct medical costs of severe hypoglycaemic events in patients with type 2 diabetes in England: A retrospective database study. Issue 6 (23rd May 2017) Authors: Holbrook, Tim; Tang, Yuexin; Das, Romita; Shankar, R. Ravi; Tunceli, Kaan; Williams, Jean; Radican, Larry; Holden, Sarah E.; Morgan, Chris Ll.; Piercy, James; Currie, Craig J. Journal: International journal of clinical practice Issue: Volume 71:Issue 6(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Double‐blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase‐4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT‐I Study. Issue 4 (9th December 2018) Authors: Roussel, Ronan; Duran‐García, Santiago; Zhang, Yilong; Shah, Suneri; Darmiento, Carolyn; Shankar, R. Ravi; Golm, Gregory T.; Lam, Raymond L. H.; O'Neill, Edward A.; Gantz, Ira; Kaufman, Keith D.; Engel, Samuel S. Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 4(2019) Page Start: 781 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin. Issue 2 (3rd October 2018) Authors: Yu, Miao; Shankar, R. Ravi; Zhang, Ruya; Zhang, Ye; Lin, Jianxin; O'Neill, Edward A.; Chen, Guojuan; Liu, Shu; Tu, Yingmei; Engel, Samuel S. Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 2(2019) Page Start: 408 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin. Issue 2 (20th December 2021) Authors: Jalaludin, Muhammad Yazid; Deeb, Asma; Zeitler, Philip; Garcia, Raymundo; Newfield, Ron S.; Samoilova, Yulia; Rosario, Carmen A.; Shehadeh, Naim; Saha, Chandan K.; Zhang, Yilong; Zilli, Martina; Scherer, Lynn W.; Lam, Raymond L. H.; Golm, Gregory T.; Engel, Samuel S.; Kaufman, Keith D.; Shankar, ... Journal: Pediatric diabetes Issue: Volume 23:Issue 2(2022) Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗